Rankings
Publications
Search Publications
Cited-By Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Login
Register
Home
Publications
Objective regressions in non-small cell lung cancer patients treated in Phase I trials of oral ZD1839 (IressaTM), a selective tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR)
Cited-By
10.1016/s0169-5002(00)80233-0
Home
Publications
Objective regressions in non-small cell lung cancer patients treated in Phase I trials of oral ZD1839 (IressaTM), a selective tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR)
Cited-By
10.1016/s0169-5002(00)80233-0
Cited-By Search
DOI
Search
Add Multiple
Add Multiple
Export
Export
Sort by
Newest first
Results per page
20
Highlight
Scroll to top